India Biosimilar Monoclonal Antibody Market Thumbnail Image

2023

India Biosimilar Monoclonal Antibody Market

India Biosimilar Monoclonal Antibody Market, by Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), by Indication (Oncology, Autoimmune diseases, Others), by End User (Hospitals, Cancer treatment centers, Others): Opportunity Analysis and Industry Forecast, 2022-2032

LS : Pharmaceuticals

  • Sep 2023

  • Pages: 76

  • Tables: 53

  • Charts: 49

Select an option
Cloud Access (30% Off) $2,175 $1,523
Business User License (30% Off) $3,255 $2,279
Enterprise License (30% Off) $5,055 $3,539
Library Membership (15% Off) $1,175 $999
Request Free Sample
Author's: Jay Mehta | Eswara Prasad
Publish Date:
Update on Demand Speak with Analyst